Drug tested to help more patients get kidney transplants
NCT ID NCT04294459
Summary
This study tested a drug called isatuximab in people waiting for a kidney transplant. The goal was to see if the drug could safely help reduce harmful antibodies in patients' blood, making them better matches for more donor kidneys. The trial was small and has been terminated, so its final results are not fully known.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE SYSTEM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :7240001
L'Hospitalet de Llobregat, Catalunya [Cataluña], 08907, Spain
-
Investigational Site Number :7240002
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Investigational Site Number :8400001
Rochester, Minnesota, 55905, United States
-
Investigational Site Number :8400002
New York, New York, 10016, United States
-
Investigational Site Number :8400003
San Francisco, California, 94143, United States
-
Investigational Site Number :8400004
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.